Efficient Rescue of Retinal Degeneration in Pde6a Mice by Engineered Base Editing and Prime Editing
Advanced Science · 2024-11 · 11 (42)
DOI: 10.1002/advs.202405628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.09.2024. Verfasst von Zhiquan Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA. Hauptthemen laut MEDLINE: Cyclic Nucleotide Phosphodiesterases, Type 6, Gene Editing, Retinal Degeneration, Disease Models, Animal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VA, P30 NIH grant, Children's Health Research Institute Award.
Abstract (Originalsprache)
Retinitis pigmentosa (RP) is a complex spectrum of inherited retinal diseases marked by the gradual loss of photoreceptor cells, ultimately leading to blindness. Among these, mutations in PDE6A, responsible for encoding a cGMP‐specific phosphodiesterase, stand out as pivotal in autosomal recessive RP (RP43). Unfortunately, no effective therapy currently exists for this specific form of RP. However, recent advancements in genome editing, such as base editing (BE) and prime editing (PE), offer a promising avenue for precise and efficient gene therapy. Here, it is illustrated that the engineered BE and PE systems, particularly PE, exhibit high efficiency in rescuing a target point mutation with minimal bystander effects in an RP mouse model carrying the Pde6a (c.2009A > G, p.D670G) mutation. The optimized BE and PE systems are first screened in N2a cells and subsequently assessed in electroporated mouse retinas. Notably, the optimal PE system, delivered via dual adeno‐associated virus (AAV), precisely corrects the pathogenic mutation with average 9.4% efficiency, with no detectable bystander editing. This correction restores PDE6A protein expression, preserved photoreceptors, and rescued retinal function in Pde6a mice. Therefore, this study offers a proof‐of‐concept demonstration for the treatment of Pde6a ‐related retinal degeneration using BE and PE systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
- Department of Ophthalmology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
- Palo Alto Veterans Administration, Palo Alto, CA, 94304, USA.
ORCID-Profile: Zhiquan Liu, Yang Sun
Förderung
- VA
- P30 NIH grant
- Children's Health Research Institute Award
- NIH HHS
- NEI NIH HHS
- Research for Prevention of Blindness Unrestricted grant
- International Retinal Research Foundation
- VA Merit
Zitieren
APA
Liu, Z., Chen, S., Davis, A. E., Lo, C. H., Wang, Q., Li, T., Ning, K., Zhang, Q., Zhao, J., Wang, S., & Sun, Y. (2024). Efficient Rescue of Retinal Degeneration in Pde6a Mice by Engineered Base Editing and Prime Editing. Advanced Science, 11(42). https://doi.org/10.1002/advs.202405628
Vancouver
Liu Z, Chen S, Davis AE, Lo CH, Wang Q, Li T, et al. Efficient Rescue of Retinal Degeneration in Pde6a Mice by Engineered Base Editing and Prime Editing. Advanced Science. 2024;11(42). doi:10.1002/advs.202405628
BibTeX
@article{Liu2024,
author = {Liu, Zhiquan and Chen, Siyu and Davis, Alexander E and Lo, Chien-Hui and Wang, Qing and Li, Tingting and Ning, Ke and Zhang, Qi and Zhao, Jingyu and Wang, Sui and Sun, Yang},
title = {Efficient Rescue of Retinal Degeneration in Pde6a Mice by Engineered Base Editing and Prime Editing},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {42},
doi = {10.1002/advs.202405628}
}
EUVIMED